Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knudsen

Showing results (31-40 of 315) with videos related to

Pageof 32
Sort By:
Drug and Alcohol Dependence|May 3, 2011
Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuationHannah K Knudsen, Jamie L Studts
Sociological Focus|April 24, 2010
Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment OrganizationsHannah K Knudsen, Paul M Roman
AIDS Care|December 22, 2009
Availability of HIV-related health services in adolescent substance abuse treatment programsH K Knudsen, C B Oser
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|March 20, 2001
Effects of exhausting exercise and catecholamines on K+ balance, acid-base status and blood respiratory properties in carpP K Knudsen, F B Jensen
Journal of Psychoactive Drugs|March 16, 2017
Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine PrescribersHannah K Knudsen, Jamie L Studts
Journal of Studies on Alcohol and Drugs|April 29, 2014
The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resourcesHannah K Knudsen, Paul M Roman
Journal of Substance Abuse Treatment|December 23, 2015
The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal StudyHannah K Knudsen, Paul M Roman
American Journal of Hospital Pharmacy|December 1, 1988
Cost-effectiveness of repackaging labetalol hydrochloride injection for intraoperative useD L Gill, A K Knudsen
The International Journal on Drug Policy|August 29, 2021
Using conjoint analysis to study health policy changes: An example from a cohort of persons who use drugsHannah K Knudsen, Jennifer R Havens
The Journal of Behavioral Health Services & Research|August 3, 2018
Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine TreatmentHannah K Knudsen, Jamie L Studts
Pageof 32

Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Drug and Alcohol Dependence|May 3, 2011
Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuationHannah K Knudsen, Jamie L Studts
Sociological Focus|April 24, 2010
Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment OrganizationsHannah K Knudsen, Paul M Roman
AIDS Care|December 22, 2009
Availability of HIV-related health services in adolescent substance abuse treatment programsH K Knudsen, C B Oser
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|March 20, 2001
Effects of exhausting exercise and catecholamines on K+ balance, acid-base status and blood respiratory properties in carpP K Knudsen, F B Jensen
Journal of Psychoactive Drugs|March 16, 2017
Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine PrescribersHannah K Knudsen, Jamie L Studts
Journal of Studies on Alcohol and Drugs|April 29, 2014
The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resourcesHannah K Knudsen, Paul M Roman
Journal of Substance Abuse Treatment|December 23, 2015
The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal StudyHannah K Knudsen, Paul M Roman
American Journal of Hospital Pharmacy|December 1, 1988
Cost-effectiveness of repackaging labetalol hydrochloride injection for intraoperative useD L Gill, A K Knudsen
The International Journal on Drug Policy|August 29, 2021
Using conjoint analysis to study health policy changes: An example from a cohort of persons who use drugsHannah K Knudsen, Jennifer R Havens
The Journal of Behavioral Health Services & Research|August 3, 2018
Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine TreatmentHannah K Knudsen, Jamie L Studts
Pageof 32